Citi tells investors it's time to sell Moderna after 600%-plus stock gains
Moderna Inc MRNA
News
Moderna Adds Chief Operating Officer Role as Company Expands into Oncology
Moderna will reveal the data for its mRNA cancer vaccine next month. Here's why it matters.
Moderna Announces Late-Breaking Data to be Presented at ESMO Congress 2026
AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033
Moderna to Present at Upcoming Conferences in September 2026
23 best-performing stocks of August, as the software industry continues its recovery
23 best-performing stocks of August, as the -2-
FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech, Novavax — Update
Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes
FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech
Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines
Moderna to Sell $2 Billion Convertible Notes in Private Placement
Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes
The Treasury, the Fed and the threat to your -2-
The Treasury, the Fed and the threat to your money
Moderna's personalized mRNA shot could reshape the fight against skin cancer - but it may also be overhyped
Moderna's cancer-vaccine breakthrough drives broad biopharma stock rally
Moderna's experimental vaccine prevents cancer recurrence, in 'historic' win for personalized medicine. Its stock soared.
Moderna Moves Back Toward Covid-Era Valuation With Latest mRNA Update
United States